List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
Bioneex Interview with the Founder and President of AptamiR Therapeutics, Dr. Marc Thibonnier

AptamiR Therapeutics is a US based preclinical-stage biotech company developing new therapies that target fat accumulation, i

Feb 17, 2023

Cancer Therapies
BioNeex Interview with the Co-Founder CEO of Oncolyze, Dr Steven Evans

Oncolyze is a New York based preclinical-stage biotech company developing a class of therapeutics to treat cancer in a new an

Oct 17, 2022

Cancer Therapies
BioNeex Interview with CEO & Founder of Quivive Pharma, Dr. John Hsu

Quivive Pharma is a San Diego-based biotech company developing next generation opioid therapeutics to prevent opioid-induced

Jun 13, 2021

Preclinical Stage
BioNeex Interview with CEO of Blue Therapeutics, Stefan Bluemmers, MD

Blue Therapeutics is a Boston based drug discovery and development biotech company. Its disruptive R2i platform technology is

May 24, 2021